Metropolitan Life Insurance CO Alector, Inc. Transaction History

Metropolitan Life Insurance CO

  • $2.27 Billion
  • Q1 2024

A detailed history of Metropolitan Life Insurance CO transactions in Alector, Inc. stock. As of the latest transaction made, Metropolitan Life Insurance CO holds 3,430 shares of ALEC stock, worth $14,886. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,430
Previous 3,430 -0.0%
Holding current value
$14,886
Previous $27,000 25.93%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$5.86 - $7.93 $7,512 - $10,166
1,282 Added 59.68%
3,430 $20,000
Q1 2023

May 15, 2023
SELL
$5.85 - $9.84 $9,997 - $16,816
-1,709 Reduced 44.31%
2,148 $13,000
Q4 2022

Jun 14, 2023
BUY
$6.88 - $9.55 $11,757 - $16,320
1,709 Added 79.56%
3,857 $35.6 Million
Q3 2022

Jun 14, 2023
BUY
$8.19 - $13.2 $13,996 - $22,558
1,709 Added 79.56%
3,857 $36.5 Million
Q2 2022

Jun 20, 2023
BUY
$7.65 - $14.24 $13,073 - $24,336
1,709 Added 79.56%
3,857 $39,000
Q1 2022

Jun 20, 2023
BUY
$13.02 - $20.78 $22,251 - $35,513
1,709 Added 79.56%
3,857 $54,000
Q1 2022

Mar 30, 2023
SELL
$13.02 - $20.78 $146,813 - $234,315
-11,276 Reduced 74.51%
3,857 $54,000
Q1 2022

May 12, 2022
SELL
$13.02 - $20.78 $146,813 - $234,315
-11,276 Reduced 74.51%
3,857 $55,000
Q4 2021

Jun 21, 2023
BUY
$19.35 - $25.54 $251,259 - $331,636
12,985 Added 604.52%
15,133 $312,000
Q3 2021

Jun 21, 2023
BUY
$21.65 - $39.49 $281,125 - $512,777
12,985 Added 604.52%
15,133 $345,000
Q2 2021

Jun 21, 2023
BUY
$15.5 - $22.48 $201,267 - $291,902
12,985 Added 604.52%
15,133 $315,000
Q2 2021

Mar 30, 2023
BUY
$15.5 - $22.48 $32,364 - $46,938
2,088 Added 16.01%
15,133 $315,000
Q2 2021

Aug 16, 2021
BUY
$15.5 - $22.48 $234,360 - $339,897
15,120 Added 116307.69%
15,133 $315,000
Q1 2021

Jun 26, 2023
BUY
$14.84 - $22.23 $161,711 - $242,240
10,897 Added 507.31%
13,045 $263 Million
Q1 2021

Mar 30, 2023
SELL
$14.84 - $22.23 $19,707 - $29,521
-1,328 Reduced 9.24%
13,045 $262,000
Q1 2021

May 14, 2021
SELL
$14.84 - $22.23 $213,102 - $319,222
-14,360 Reduced 99.91%
13 $263,000
Q4 2020

Jun 22, 2023
BUY
$9.4 - $16.7 $114,915 - $204,157
12,225 Added 569.13%
14,373 $217,000
Q3 2020

Jun 26, 2023
BUY
$10.54 - $24.96 $128,851 - $305,136
12,225 Added 569.13%
14,373 $151,000
Q2 2020

Jun 26, 2023
BUY
$21.87 - $33.11 $267,360 - $404,769
12,225 Added 569.13%
14,373 $351,000
Q2 2020

Mar 30, 2023
BUY
$21.87 - $33.11 $87,064 - $131,810
3,981 Added 38.31%
14,373 $351,000
Q2 2020

Aug 14, 2020
BUY
$21.87 - $33.11 $87,064 - $131,810
3,981 Added 38.31%
14,373 $351,000
Q1 2020

Jul 12, 2023
BUY
$16.25 - $35.28 $133,965 - $290,848
8,244 Added 383.8%
10,392 $250,000
Q1 2020

Mar 30, 2023
BUY
$16.25 - $35.28 $11,277 - $24,484
694 Added 7.16%
10,392 $250,000
Q1 2020

May 15, 2020
BUY
$16.25 - $35.28 $11,277 - $24,484
694 Added 7.16%
10,392 $251,000
Q4 2019

Jul 12, 2023
BUY
$14.17 - $20.3 $106,983 - $153,265
7,550 Added 351.49%
9,698 $167,000
Q4 2019

Mar 30, 2023
SELL
$14.17 - $20.3 $10,372 - $14,859
-732 Reduced 7.02%
9,698 $167,000
Q4 2019

Feb 14, 2020
SELL
$14.17 - $20.3 $10,372 - $14,859
-732 Reduced 7.02%
9,698 $167,000
Q3 2019

Jul 12, 2023
BUY
$14.42 - $22.2 $119,426 - $183,860
8,282 Added 385.57%
10,430 $150,000
Q3 2019

Mar 30, 2023
BUY
$14.42 - $22.2 $94,782 - $145,920
6,573 Added 170.42%
10,430 $150,000
Q3 2019

Nov 14, 2019
BUY
$14.42 - $22.2 $150,400 - $231,546
10,430 New
10,430 $150,000

Others Institutions Holding ALEC

# of Institutions
161
Shares Held
59.8M
Call Options Held
67.8K
Put Options Held
200
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $358M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email